AKT1 and prostate adenocarcinoma: First, UC-MSC secretome and CBS are able to significantly decrease cell viability, cell proliferation, inhibit the migratory behavior and decrease PI3K/AKT activation of both androgen-nonresponsive and androgen-sensitive human prostate adenocarcinoma cell lines.